Efficacy analysis of gasless robotic surgery via transaxillary approach for unilateral N1b PTC.
10.13201/j.issn.2096-7993.2025.11.003
- Author:
Faya LIANG
1
;
Xin ZOU
1
;
Peiliang LIN
1
;
Ping HAN
1
;
Renhui CHEN
1
;
Xijun LIN
1
;
Jingyi WANG
1
;
Xiangwei KONG
1
;
Lanlan DENG
1
;
Xiaoming HUANG
1
Author Information
1. Department of Otolaryngology-Head and Neck Surgery，Sun Yat-sen Memorial Hospital，Sun Yat-sen University，Key Laboratory of Epigenetics and Gene Regulation of Malignant Tumor in Guangdong Province，Guangzhou，510280，China.
- Publication Type:Journal Article
- Keywords:
efficacy;
gasless;
papillary thyroid carcinoma;
robotic surgery;
transaxillary approach
- MeSH:
Humans;
Robotic Surgical Procedures/methods*;
Axilla/surgery*;
Male;
Female;
Operative Time;
Middle Aged;
Adult;
Treatment Outcome;
Postoperative Complications
- From:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
2025;39(11):1009-1015
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To compare the efficacy of gasless robotic surgery via transaxillary approach and combined axillary-retroauricular approach for unilateral N1b PTC, and to explore the safety and effectiveness of gasless robotic surgery via transaxillary approach for unilateral N1b PTC. Methods:Unilateral N1b PTC patients who underwent surgery in the Department of Otolaryngology, Sun Yat Sen Memorial Hospital, Sun Yat sen University between July 2016 and December 2024 were included and analyzed. According to the inclusion and exclusion criteria and the differences of surgical approaches, the patients were divided into the transaxillary approach（TA） group and the combined axillary-retroauricular approach（TARA） group. The demographic data, operation time, intraoperative blood loss, postoperative drainage volume, postoperative complications, shoulder function evaluation, postoperative visual analogue scale（VAS） of neck aesthetics and recurrence of the two groups were statistically analyzed. Results:A total of 88 patients undergoing gasless robotic surgery were included in this study, including 23 cases in the TA group and 65 cases in the TARA group. The proportion of males in the TA group was significantly higher than that in the TARA group（56.5% vs 21.5%, χ²=9.776, P=0.002）. The total operation time in the TA group was significantly lower than that in the TARA Group（180.00[155.00, 220.00]min vs 220.00[177.50, 272.50]min, z=-2.775, P=0.006）, and the postoperative blood loss in the TA group was significantly lower than that in the TARA Group（30.00[20.00, 50.00]ml vs 50.00[30.00, 60.00]ml, Z=-2.127, P=0.033）. The proportion of area Ⅱ-Ⅴ in the TA group and the TARA group was 87.0% and 70.8%, respectively, and there was no significant difference between the two groups（P>0.05）. There was no significant difference in lateral cervical lymph node dissection and central lymph node dissection between the two groups（P>0.05）. During the follow-up period, no recurrence was found in the two groups, and there was no significant difference in the incidence of complications between the two groups（P>0.05）. According to the stratification of dynamic recurrence risk assessment, it can be seen that the proportion of curative effect satisfaction in the TA group was as high as 95.7%, and that in the TARA group was as high as 81.5%, with no significant difference between the two groups. There was no significant difference in VAS score of neck, Constant Shoulder Score and NDⅡ scale between the two groups（P>0.05）. Conclusion:Gasless robotic surgery via transaxillary approach for unilateral N1b PTC is safe and feasible, and the amount postoperative lymph node acquisition is equivalent to that of combined axillary-retroauricular approach, which can provide a new choice for the treatment of unilateral N1b PTC patients.
